Comparing the longer regimen and the shorter regimen for multidrug-resistant pulmonary tuberculosis patients treated under the programmatic management of drug-resistant tuberculosis.

( 31 ) found that while patients with unknown DM status and those with DM had higher rates of unfavorable outcomes (23% and 17%, respectively), the difference was not statistically significant, however, poor glycemic control or unknown control status showed a trend toward increased risk of unfavorable outcomes.

also in 53,322 other papers